mevalonic acid has been researched along with Muscular Diseases in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 4 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Britza, SM; Byard, RW; Farrington, R; Musgrave, IF; Zechner, J | 1 |
| Kashfi, K; Patel, KK; Sehgal, VS | 1 |
| Birk, OS; Davidov, G; Dolgin, V; Drabkin, M; Hadar, N; Halperin, D; Koifman, A; Nudelman, H; Perez, Y; Proskorovski-Ohayon, R; Shelef, I; Shorer, Z; Wormser, O; Yogev, Y; Zarivach, R | 1 |
| Bharucha-Goebel, D; Bönnemann, CG; Boyum, GE; Bruels, CC; Chao, KR; Clark, KJ; Cong, ATQ; Donkervoort, S; Estrella, EA; Foley, AR; Grunseich, C; Hu, Y; Kang, PB; Klee, EW; Lee, B; Littel, HR; Lotze, TE; Lupski, JR; Macklin-Mantia, SK; Mohila, CA; Morales-Rosado, JA; Pais, L; Pehlivan, D; Pinto E Vairo, F; Rosenfeld, JA; Saade, D; Schellenberg, MJ; Schwab, TL; Wierenga, KJ; Zimmermann, MT | 1 |
| Gee, RH; Johnston, JD; Malia, JM; Plant, KE; Plant, NJ; Spinks, JN | 1 |
| Ishibashi, S; Ishii, A; Iwasaki, H; Kobayashi, K; Matsuzaka, T; Miyahara, S; Nakagawa, Y; Ohashi, K; Osaki, Y; Shimano, H; Sone, H; Suzuki, H; Takahashi, A; Yahagi, N; Yamada, N; Yatoh, S | 1 |
| Bełtowski, J; Jamroz-Wiśniewska, A; Wójcicka, G | 1 |
| Chang, CJ; Chow, CY; Hsiao, CD; Huang, SH; Liau, I; Lin, DS | 1 |
| Gotto, AM; Vaughan, CJ | 1 |
| Baker, SK; Tarnopolsky, MA | 2 |
| Anayama, H; Hamajyo, H; Hirakata, M; Ishikawa, E; Nagai, H; Nishimoto, T; Tozawa, R | 1 |
| Illingworth, DR; Maher, VM; Pappu, A; Thompson, GR | 1 |
5 review(s) available for mevalonic acid and Muscular Diseases
| Article | Year |
|---|---|
Flavonoid-statin interactions causing myopathy and the possible significance of OATP transport, CYP450 metabolism and mevalonate synthesis.
Topics: Cardiovascular Diseases; Cytochrome P-450 Enzyme System; Drug Interactions; Flavonoids; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Mevalonic Acid; Muscular Diseases; Myotoxicity; Organic Anion Transporters; Risk Factors | 2022 |
Molecular targets of statins and their potential side effects: Not all the glitter is gold.
Topics: Diabetes Mellitus, Type 2; Gold; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Muscular Diseases | 2022 |
Adverse effects of statins - mechanisms and consequences.
Topics: Cardiovascular System; Chemical and Drug Induced Liver Injury; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lipid Metabolism; Mevalonic Acid; Muscular Diseases; Nervous System Diseases; Rhabdomyolysis; Risk Assessment; Risk Factors; Signal Transduction | 2009 |
Update on statins: 2003.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Cholesterol, LDL; Creatine Kinase; Creatine Kinase, MM Form; Drug Interactions; Female; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Inactivation, Metabolic; Isoenzymes; Male; Mevalonic Acid; Middle Aged; Models, Biological; Muscular Diseases; Prospective Studies; Protein Prenylation; Randomized Controlled Trials as Topic; Structure-Activity Relationship | 2004 |
Statin-associated neuromyotoxicity.
Topics: Acyl Coenzyme A; Adverse Drug Reaction Reporting Systems; Cholesterol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Muscular Diseases; Peripheral Nervous System Diseases; Rhabdomyolysis; Terpenes; Ubiquinone | 2005 |
9 other study(ies) available for mevalonic acid and Muscular Diseases
| Article | Year |
|---|---|
Limb girdle muscular disease caused by
Topics: Animals; Autoantibodies; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Mice; Muscular Diseases; Mutation | 2023 |
Bi-allelic variants in HMGCR cause an autosomal-recessive progressive limb-girdle muscular dystrophy.
Topics: Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Muscular Diseases; Muscular Dystrophies; Muscular Dystrophies, Limb-Girdle; Oxidoreductases | 2023 |
Inhibition of prenyltransferase activity by statins in both liver and muscle cell lines is not causative of cytotoxicity.
Topics: Alkyl and Aryl Transferases; Cell Line, Tumor; Dimethylallyltranstransferase; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Liver; Membrane Proteins; Mevalonic Acid; Muscle, Skeletal; Muscular Diseases; Prenylation; Protein Processing, Post-Translational; rap1 GTP-Binding Proteins; Simvastatin | 2015 |
Coenzyme Q10 and statin-related myopathy.
Topics: Energy Transfer; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Muscular Diseases; Ubiquinone | 2015 |
Skeletal muscle-specific HMG-CoA reductase knockout mice exhibit rhabdomyolysis: A model for statin-induced myopathy.
Topics: Animals; Cholesterol; Creatine Kinase; Disease Models, Animal; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mevalonic Acid; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Skeletal; Muscular Diseases; Rhabdomyolysis; RNA, Messenger | 2015 |
Imaging of zebrafish in vivo with second-harmonic generation reveals shortened sarcomeres associated with myopathy induced by statin.
Topics: Animals; Cholesterol; Dose-Response Relationship, Drug; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Processing, Computer-Assisted; Larva; Male; Mevalonic Acid; Microfibrils; Microscopy, Fluorescence, Multiphoton; Muscle Contraction; Muscle, Skeletal; Muscular Diseases; Sarcomeres; Time Factors; Zebrafish | 2011 |
Statin-associated neuromyotoxicity.
Topics: Creatine Kinase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Muscle Cramp; Muscular Diseases; Peripheral Nervous System Diseases | 2005 |
Protective effects of a squalene synthase inhibitor, lapaquistat acetate (TAK-475), on statin-induced myotoxicity in guinea pigs.
Topics: Animals; Biomarkers; Cholesterol; Creatine Kinase; Drug Antagonism; Drug Therapy, Combination; Enzyme Inhibitors; Farnesyl-Diphosphate Farnesyltransferase; Guinea Pigs; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mevalonic Acid; Muscle, Skeletal; Muscular Diseases; Oxazepines; Piperidines; Pyridines | 2007 |
Plasma mevalonate response in lovastatin-related myopathy.
Topics: Aged; Creatine Kinase; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Mevalonic Acid; Middle Aged; Muscular Diseases | 1989 |